Why the study?
Does intracoronary nicardipine reverse no-reflow in patients undergoing percutaneous coronary intervention?
Population
Patients experiencing no-reflow during percutaneous coronary intervention (PCI)
Design
Case_series
Authors
Loading...
May support nicardipine for no-reflow reversal in PCI; leaves open need for randomized confirmation before practice change.
Does intracoronary nicardipine reverse no-reflow in patients undergoing percutaneous coronary intervention?
Intracoronary nicardipine appears safe and effective for reversing no-reflow during PCI based on this case series.
Huang et al. (2006) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: